Christopher Storbeck

Dr. Storbeck is a Senior Quality Evaluator in the Cell, Gene Therapies and Radiopharmaceuticals Division in the Center for Oncology, Radiopharmaceuticals and Research at Health Canada. Prior to joining Health Canada, Dr. Storbeck worked as a product development scientist evaluating novel therapeutic product candidates in a small Biotech firm focussed on Oncolytic Virus product development. Dr. Storbeck holds a Ph.D from the University of Ottawa studying the disease mechanism of Myotonic Muscular Dystrophy and conducted post-doctoral studies evaluating the role of protein kinase regulatory molecules in cancer cell migration and metastasis.